Disitamab Vedotin combined with Sintilimab

DRUG2 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, Xiangya Hospital of Central South University

Conditions

Gastric Cancer

Phase 2

Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer

Tianjin Medical University Cancer Institute and HospitalGastric Cancer

Start: 2023-03-01End: 2025-03-01Target: 20Updated: 2023-02-09

Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab

Xiangya Hospital of Central South UniversityGastric Cancer

Start: 2023-07-01End: 2025-07-01Target: 30Updated: 2023-07-05